Patents by Inventor Bruce Duncan Irvine

Bruce Duncan Irvine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Devices and methods for biochip multiplexing
    Publication number: 20040053290
    Abstract: The invention is directed to devices that allow for simultaneous multiple biochip analysis. In particular, the devices are configured to hold multiple cartridges comprising biochips comprising arrays such as nucleic acid arrays, and allow for high throughput analysis of samples.
    Type: Application
    Filed: April 11, 2003
    Publication date: March 18, 2004
    Inventors: Robert Henry Terbrueggen, Gary F. Blackburn, Marc Kenneth Chason, Xunhu Dai, Manes Eliacin, Piotr Grodzinski, Bruce Duncan Irvine, Jon Faiz Kayyem, Keryn Ke Lian, Robin Hui Liu, Shawn Michael O'Rourke, Edward Lewis Sheldon, Frederic Zenhausern
  • NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
    Patent number: 5714596
    Abstract: A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers comprised of polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.
    Type: Grant
    Filed: March 31, 1993
    Date of Patent: February 3, 1998
    Assignee: Chiron Corporation
    Inventors: Michael Houghton, Qui-Lim Choo, George Kuo, Amy J. Weiner, Jang Han, Michael Steven Urdea, Bruce Duncan Irvine, Janice A. Kolberg
  • Methods for detecting Hepatitis C virus using polynucleotides specific for same
    Patent number: 5712088
    Abstract: A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers containing polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: January 27, 1998
    Assignee: Chiron Corporation
    Inventors: Michael Houghton, Qui-Lim Choo, George Kuo, Amy J. Weiner, Jang Han, Michael Steven Urdea, Bruce Duncan Irvine, Janice A. Kolberg